| NCT ID | NCT06526143 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Yale University |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,800 participants |
| Start Date | 2024-09-18 |
| Primary Completion | 2028-07 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,800 participants in total. It began in 2024-09-18 with a primary completion date of 2028-07.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this 2-cohort, cluster randomized, type 2 hybrid trial is to test the effectiveness, cost-effectiveness and patient-level effects of an implementation facilitation strategy in helping M2VA case managers adopt a Military2VA Pain Care Pathway (M2VAPCP) intervention. The main questions it aims to answer are: Will adding implementation facilitation to training-as-usual for M2VAPCP result in a higher proportion of Veterans who receive M2VAPCP compared to training-as-usual alone? Will adding implementation facilitation to training-as-usual for M2VAPCP result in better adherence to the M2VAPCP protocol compared to training-as-usual alone? Will implementation facilitation improve Veterans' clinical outcomes (pain, risky substance use) and increase the number of non-pharmacological pain treatments used compared to training-as-usual alone?
Eligibility Criteria
Inclusion Criteria: * Study enrollment is within one year of ending military service * Has filed a service-connection claim for an MSD (back, neck, knee, or shoulder condition) * Lives within the catchment area of a participating site Exclusion Criteria: * Reports being unable to complete planned study assessments because of anticipated incapacity, incarceration, or other reason * Does not have a landline or cell phone to complete study assessments * Is unable to provide informed consent * Still on active duty
Contact & Investigator
Marc Rosen, MD
PRINCIPAL INVESTIGATOR
Yale University
Frequently Asked Questions
Who can join the NCT06526143 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06526143 currently recruiting?
Yes, NCT06526143 is actively recruiting participants. Contact the research team at christina.lazar@yale.edu for enrollment information.
Where is the NCT06526143 trial being conducted?
This trial is being conducted at West Haven, United States.
Who is sponsoring the NCT06526143 clinical trial?
NCT06526143 is sponsored by Yale University. The principal investigator is Marc Rosen, MD at Yale University. The trial plans to enroll 1,800 participants.